0001104659-20-138761.txt : 20201222 0001104659-20-138761.hdr.sgml : 20201222 20201222204112 ACCESSION NUMBER: 0001104659-20-138761 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20201222 FILED AS OF DATE: 20201222 DATE AS OF CHANGE: 20201222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Freeman Roy Lester CENTRAL INDEX KEY: 0001799732 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39676 FILM NUMBER: 201409531 MAIL ADDRESS: STREET 1: 256 SUMMIT AVE CITY: BROOKLINE STATE: MA ZIP: 02446 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inhibikase Therapeutics, Inc. CENTRAL INDEX KEY: 0001750149 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3350 RIVERWOOD PARKWAY SE, SUITE 1900 CITY: ATLANTA STATE: GA ZIP: 30339 BUSINESS PHONE: 678-392-3419 MAIL ADDRESS: STREET 1: 3350 RIVERWOOD PARKWAY SE, SUITE 1900 CITY: ATLANTA STATE: GA ZIP: 30339 3 1 tm2034420d5_form3.xml FORM 3 X0206 3 2020-12-22 0 0001750149 Inhibikase Therapeutics, Inc. IKT 0001799732 Freeman Roy Lester 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 1 0 0 0 Stock Option (right to buy) 5.57 2019-07-29 2026-07-28 Common Stock 87415 D Stock Option (right to buy) 5.57 2026-07-28 Common Stock 43707 D The number of shares has been adjusted to reflect a one-for-1.14396 reverse stock split of the Issuer's common stock effected on August 24, 2020 (the "Reverse Split") and excludes fractional shares resulting from the Reverse Split, which shall be paid in cash upon exercise. The exercise price has been adjusted to reflect the Reverse Split. The option vests in twenty-four equal monthly installments beginning on July 29, 2019. Exhibit List: Exhibit 24 - Power of Attorney /s/ Milton H. Werner, attorney-in-fact 2020-12-22 EX-24 2 tm2034420d5_ex24.htm POWER OF ATTORNEY

 

Exhibit 24

 

POWER OF ATTORNEY

 

KNOW ALL BY THESE PRESENTS, that the undersigned hereby constitutes and appoints Milton Werner with full power to act, as the undersigned’s true and lawful attorney-in-fact, with full power of substitution, to:

 

1)execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer and/or director and/or beneficial owner of Inhibikase Therapeutics, Inc. (the “Company”), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules thereunder;

 

2)do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and

 

3)take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.

 

The undersigned hereby grants to the attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted.

 

This power of attorney shall remain in full force and effect until revoked by the undersigned in a signed writing delivered to the attorney-in-fact.

 

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 27th day of October, 2020.

 

 

  By: /s/ Roy Freeman
  Name: Roy Freeman
  Title: MD